Subsequent Event (Details) - Subsequent Event [Member] |
Aug. 31, 2026 |
|---|---|
| Aspire Science [Member] | |
| Subsequent Event [Line Items] | |
| Equity interest | 49.00% |
| Jincheng Pharmaceutical And Chemical [Member] | |
| Subsequent Event [Line Items] | |
| Equity interest | 51.00% |
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|